4basebio PLC (AIM:4BB)
London flag London · Delayed Price · Currency is GBP · Price in GBX
525.00
0.00 (0.00%)
Jul 24, 2026, 3:53 PM GMT

4basebio Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1.690.930.510.270.34
Revenue Growth (YoY)
81.46%84.39%88.81%-20.71%-26.84%
Cost of Revenue
0.720.30.170.030.07
Gross Profit
0.970.630.340.240.27
Selling, General & Admin
17.713.878.812.961.86
Research & Development
---2.081.62
Other Operating Expenses
0.87-1.19-0.421.040.32
Total Operating Expenses
18.5712.678.396.083.8
Operating Income
-17.6-12.04-8.05-5.84-3.53
Interest Income
0.880.140--
Interest Expense
-0.89-0.75-0.3-0.09-0.11
Total Non-Operating Income (Expense)
-0-0.61-0.3-0.09-0.11
Pretax Income
-17.6-12.65-8.35-5.93-3.64
Provision for Income Taxes
-0.7-0.32-0.69-0.78-0.41
Net Income
-16.91-12.33-7.67-5.15-3.24
Net Income to Common
-16.91-12.33-7.67-5.15-3.24
Net Income Growth
-----
Shares Outstanding (Basic)
1613121212
Shares Outstanding (Diluted)
1613121212
Shares Change (YoY)
18.26%6.47%0.01%-33.93%
EPS (Basic)
-1.09-0.94-0.62-0.42-0.26
EPS (Diluted)
-1.09-0.94-0.62-0.42-0.26
EPS Growth
-----
Free Cash Flow
-16.06-11.44-7.05-5.86-3.62
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-1.04-0.87-0.57-0.48-0.29
Gross Margin
57.53%67.52%67.19%89.18%79.59%
Operating Margin
-1039.57%-1290.68%-1591.30%-2179.10%-1043.49%
Profit Margin
-998.52%-1321.86%-1514.82%-1921.64%-957.10%
FCF Margin
-948.49%-1226.26%-1393.08%-2186.19%-1072.19%
EBITDA
-16.46-11.11-7.34-5.41-3.21
EBITDA Margin
-971.94%-1190.68%-1451.19%-2018.28%-948.82%
EBIT
-17.6-12.04-8.05-5.84-3.53
EBIT Margin
-1039.57%-1290.68%-1591.30%-2179.10%-1043.49%
Effective Tax Rate
3.97%2.54%8.25%13.14%11.13%